Case number 1:20-cv-00968
AbbVie Inc. et al v. Dr. Reddys Laboratories, Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 26, 2023 | 191 | Amended Complaint* (1) |
| Jul 26, 2023 | 188 | Amended Complaint* (1) |
| Jun 23, 2023 | 185 | SO ORDERED, re 184 STIPULATION TO EXTEND TIME for Plaintiffs to Serve Final Infringement Contentions to July 26, 2023. Signed by Judge Mitchell S. Goldberg on 6/23/2023. (twk) (Entered: 06/23/2023) (2) |
| Jun 22, 2023 | 184 | STIPULATION TO EXTEND TIME for Plaintiffs to Serve Final Infringement Contentions to July 26, 2023 - filed by AbbVie Inc.. (Streifthau-Livizos, Michelle) (Entered: 06/22/2023) (2) |
| Jun 13, 2023 | 183 | ORDER, Upon consideration of the parties' Amended Joint Claim Construction Chart (ECF No. 181 ) in which the parties set forth their agreed upon constructions for the previously disputed terms of the '599 patent, it is hereby ORDERED that the Markman Hearing scheduled for Wednesday June 14, 2023 in the above-captioned matter is CANCELLED. Signed by Judge Mitchell S. Goldberg on 6/13/2023. (apk) (Entered: 06/13/2023) (1) |
| Jun 12, 2023 | 181 | CLAIM Construction Chart by AbbVie Inc.. (Streifthau-Livizos, Michelle) (Entered: 06/12/2023) (5) |
| Jun 12, 2023 | 182 | SO ORDERED, re 181 Amended Claim Construction Chart filed by AbbVie Inc. Signed by Judge Mitchell S. Goldberg on 06/12/2023. (smg) (Entered: 06/12/2023) (5) |
| Jun 8, 2023 | 180 | ORDER: The Markman hearing in the above-captioned matter scheduled for Wednesday, June 14, 2023 at 10:00 a.m. in Wilmington, Delaware will be held in Courtroom 6-A. Signed by Judge Mitchell S. Goldberg on 06/08/2023. (smg) (Entered: 06/08/2023) (1) |
| May 12, 2023 | 177 | Letter to The Honorable Mitchell S. Goldberg from Samantha G. Wilson regarding Defendants' Technology Tutorial. (Attachments: # 1 Defendants' Technology Tutorial)(Wilson, Samantha) (Entered: 05/12/2023) (Main Document) (1) |
| May 12, 2023 | 178 | CLAIM CONSTRUCTION REPLY BRIEF filed by AbbVie Inc.. (Attachments: # 1 Plaintiffs' Technology Tutorial)(Streifthau-Livizos, Michelle) (Entered: 05/12/2023) (Main Document) (19) |
| May 12, 2023 | 179 | CLAIM CONSTRUCTION REPLY BRIEF filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Wilson, Samantha) (Entered: 05/12/2023) (20) |
| May 12, 2023 | 177 | Letter to The Honorable Mitchell S. Goldberg from Samantha G. Wilson regarding Defendants' Technology Tutorial. (Attachments: # 1 Defendants' Technology Tutorial)(Wilson, Samantha) (Entered: 05/12/2023) (Defendants' Technology Tutorial) (14) |
| May 12, 2023 | 178 | CLAIM CONSTRUCTION REPLY BRIEF filed by AbbVie Inc.. (Attachments: # 1 Plaintiffs' Technology Tutorial)(Streifthau-Livizos, Michelle) (Entered: 05/12/2023) (Plaintiffs' Technology Tutorial) (19) |
| Apr 26, 2023 | 175 | CLAIM CONSTRUCTION ANSWERING BRIEF re 170 Claim Construction Opening Brief filed by AbbVie Inc.. (Streifthau-Livizos, Michelle) (Entered: 04/26/2023) (18) |
| Apr 26, 2023 | 176 | CLAIM CONSTRUCTION ANSWERING BRIEF of Defendants filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Wilson, Samantha) (Entered: 04/26/2023) (20) |
| Apr 19, 2023 | 173 | NOTICE of Appearance by Daniel Taylor on behalf of Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd. (Taylor, Daniel) (Entered: 04/19/2023) (1) |
| Apr 19, 2023 | 174 | ORDER, Markman hearing in the above-captioned matter is scheduled for Wednesday, June 14, 2023 at 10:00 a.m. in Wilmington, Delaware in a courtroom to be determined. Signed by Judge Mitchell S. Goldberg on 4/19/2023. (twk) (Entered: 04/19/2023) (1) |
| Apr 18, 2023 | 172 | NOTICE OF SERVICE of Plaintiffs' Supplemental Objections and Responses to Defendants' First Set of Joint Interrogatories (No.1) filed by AbbVie Inc..(Streifthau-Livizos, Michelle) (Entered: 04/18/2023) (2) |
| Apr 14, 2023 | 171 | NOTICE OF SERVICE of Plaintiffs' Second Amended Paragraph 3 Disclosures filed by AbbVie Inc..(Streifthau-Livizos, Michelle) (Entered: 04/14/2023) (2) |
| Mar 31, 2023 | 169 | CLAIM CONSTRUCTION OPENING BRIEF Plaintiffs' Opening Claim Construction Brief filed by AbbVie Inc.. (Attachments: # 1 Exhibit 1)(Streifthau-Livizos, Michelle) (Entered: 03/31/2023) (Main Document) (21) |
| Mar 31, 2023 | 170 | CLAIM CONSTRUCTION OPENING BRIEF filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1 through 7)(Wilson, Samantha) (Entered: 03/31/2023) (Main Document) (29) |
| Mar 31, 2023 | 169 | CLAIM CONSTRUCTION OPENING BRIEF Plaintiffs' Opening Claim Construction Brief filed by AbbVie Inc.. (Attachments: # 1 Exhibit 1)(Streifthau-Livizos, Michelle) (Entered: 03/31/2023) (Exhibit 1) (30) |
| Mar 31, 2023 | 170 | CLAIM CONSTRUCTION OPENING BRIEF filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1 through 7)(Wilson, Samantha) (Entered: 03/31/2023) (Exhibit 1 through 7) (30) |
| Mar 20, 2023 | 168 | NOTICE OF SERVICE of Objections and Responses to Second Set of Joint Request for the Production of Documents and Things (nos. 91 - 100) filed by AbbVie Inc., Genentech, Inc..(Streifthau-Livizos, Michelle) Modified on 3/21/2023 (mkr). (Entered: 03/20/2023) (3) |
| Mar 17, 2023 | 165 | NOTICE of Withdrawal of Appearance of Delaware Counsel, Eve Ormerod by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd. (Belgam, Neal) (Entered: 03/17/2023) (1) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Main Document) (8) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 1) (30) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 2) (30) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 3) (21) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 4) (19) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 5) (15) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 6) (17) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 7) (9) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 8) (22) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 9) (3) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 10) (30) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 11) (14) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 12) (30) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 13) (15) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 14) (26) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 15) (13) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 16) (23) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 17) (10) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 18) (22) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 19) (10) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 20) (3) |
| Mar 17, 2023 | 166 | CLAIM Construction Chart by AbbVie Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21)(Streifthau-Livizos, Michelle) (Entered: 03/17/2023) (Exhibit 21) (10) |
| Mar 16, 2023 | 164 | NOTICE OF SERVICE of Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc., and Alembic Global Holdings SA's Supplemental Response and Objections to Plaintiffs' Interrogatory No. 9 filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Wilson, Samantha) (Entered: 03/16/2023) (2) |
| Mar 10, 2023 | 161 | STIPULATION AND ORDER regarding D.I. 160 . Signed by Judge Mitchell S. Goldberg on 03/10/2023. (apk) (Entered: 03/10/2023) (2) |
| Mar 10, 2023 | 162 | Joint STIPULATION TO EXTEND TIME Submission of Joint Claim Construction Statement for '599 patent to March 17, 2023 - filed by AbbVie Inc., Genentech, Inc.. (Taylor, James) (Entered: 03/10/2023) (2) |
| Mar 10, 2023 | 163 | STIPULATION AND ORDER regarding D.I. 162 . Signed by Judge Mitchell S. Goldberg on 03/10/2023. (apk) (Entered: 03/10/2023) (2) |
| Mar 7, 2023 | 160 | STIPULATION TO EXTEND TIME for Substantial Completion of Document Production for the '599 Patent from March 17, 2023 to April 14, 2023 - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) (Entered: 03/07/2023) (2) |
| Feb 28, 2023 | 159 | NOTICE OF SERVICE of Defendants' Preliminary Identification of Claim Terms and Proposed Constructions for U.S. Patent No. 11,369,599 filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Wilson, Samantha) (Entered: 02/28/2023) (2) |
| Feb 24, 2023 | 158 | NOTICE OF SERVICE of Plaintiffs' Proposed Terms for Claim Construction and Proposed Constructions filed by AbbVie Inc., Genentech, Inc..(Streifthau-Livizos, Michelle) (Entered: 02/24/2023) (2) |
| Feb 23, 2023 | 157 | NOTICE OF SERVICE of Defendants' Second Set of Joint Requests for the Production of Documents and Things (Nos. 91-100) filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Wilson, Samantha) (Entered: 02/23/2023) (2) |
| Feb 17, 2023 | 156 | NOTICE of Withdrawal of pro hac vice Counsel, Beth Finkelstein by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd. (Ormerod, Eve) (Entered: 02/17/2023) (1) |
| Feb 16, 2023 | 155 | NOTICE OF SERVICE of Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd's First Supplemental Objections and Responses to Plaintiffs' Third Set of Interrogatories (Nos. 10-13) filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Ormerod, Eve) (Entered: 02/16/2023) (2) |
| Feb 13, 2023 | 154 | NOTICE OF SERVICE of Alembic's Separate and Confidential Initial Invalidity Contentions for U.S. Patent No. 11,369,599 (ALEMBIC ONLY) filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Wilson, Samantha) (Entered: 02/13/2023) (2) |
| Feb 10, 2023 | 153 | NOTICE OF SERVICE of Defendants' Invalidity Contentions for U.S. Patent No. '599 filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Ormerod, Eve) (Entered: 02/10/2023) (1) |
| Jan 23, 2023 | 152 | NOTICE requesting Clerk to remove Robert W. Stout as co-counsel.. (Wilson, Samantha) (Entered: 01/23/2023) (3) |
| Jan 20, 2023 | 151 | SO ORDERED, re D.I. 150 MOTION for Pro Hac Vice Appearance of Attorney Tyler C. Liu and Attorney Sasha S. Rao filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc. Signed by Judge Mitchell S. Goldberg on 01/20/2023. (smg) (Entered: 01/20/2023) (2) |
| Jan 7, 2023 | 150 | MOTION for Pro Hac Vice Appearance of Attorney Tyler C. Liu and Attorney Sasha S. Rao - filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Wilson, Samantha) (Entered: 01/07/2023) (5) |
| Dec 16, 2022 | 149 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions for the 599 Patent filed by AbbVie Inc..(Streifthau-Livizos, Michelle) (Entered: 12/16/2022) (2) |
| Dec 2, 2022 | 148 | NOTICE requesting Clerk to remove Aubrey J. Morin as co-counsel. Reason for request: No longer with the firm of Saul Ewing LLP. (Morin, Aubrey) (Entered: 12/02/2022) (2) |
| Nov 18, 2022 | 147 | ANSWER to 146 Answer to Amended Complaint,, Counterclaim, Plaintiff's Reply to Alembic's Counterclaims in Defendants' Answer to Third Amended Complaint by AbbVie Inc..(Streifthau-Livizos, Michelle) (Entered: 11/18/2022) (11) |
| Oct 28, 2022 | 145 | ANSWER to Amended Complaint, re: 140 Amended Complaint Answer and Separate Defenses of Defendants Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc. to Plaintiffs Third Amended Complaint Against DRL For Patent Infringement by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Ormerod, Eve) (Entered: 10/28/2022) (26) |
| Oct 28, 2022 | 146 | ANSWER to Amended Complaint, re: 137 Amended Complaint , COUNTERCLAIM against All Plaintiffs by Alembic Pharmaceuticals, Inc., Alembic Global Holding SA, Alembic Pharmaceuticals Ltd..(Gaza, Anne) Modified on 10/31/2022 (srs). (Entered: 10/28/2022) (30) |
| Oct 21, 2022 | 143 | NOTICE of Withdrawal of Pro Hac Vice Appearance by AbbVie Inc. re 123 Order on Motion to Appear Pro Hac Vice (Streifthau-Livizos, Michelle) (Entered: 10/21/2022) (2) |
| Oct 21, 2022 | 144 | STIPULATION AND ORDER regarding D.I. 134 . Signed by Judge Mitchell S. Goldberg on 10/21/2022. (apk) (Entered: 10/21/2022) (3) |
| Oct 7, 2022 | 140 | Amended Complaint* (1) |
| Oct 7, 2022 | 137 | Amended Complaint* (1) |
| Oct 7, 2022 | 141 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Date of Expiration of Patent:. (Streifthau-Livizos, Michelle) (Entered: 10/07/2022) (2) |
| Oct 7, 2022 | 142 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10999942 ;11110087 ;11369599 . (Streifthau-Livizos, Michelle) (Entered: 10/07/2022) (1) |
| Jul 5, 2022 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Telephone Conference held on 7/5/2022. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG(smg) |
| Jul 5, 2022 | 126 | Order (1) Docket Text: ORDER: The Markman hearing scheduled for July 12, 2022 at 9:00 am is CANCELLED. Signed by Judge Mitchell S. Goldberg on 07/05/2022. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG(smg) |
| Jun 29, 2022 | 125 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Charles E. Davis as co-counsel. Reason for request: No longer with the firm of Saul Ewing Arnstein & Lehr LLP. (Streifthau-Livizos, Michelle) |
| Jun 16, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Andrea P. Brockway for AbbVie Inc. and Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Jun 16, 2022 | 124 | Notice (Other) (1) Docket Text: NOTICE of of Withdrawal of Appearance of Anandita Vyakarnam by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. (Ormerod, Eve) |
| Jun 14, 2022 | 122 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Andrea Brockway - filed by AbbVie Inc.. (Taylor, James) |
| Jun 14, 2022 | 123 | Order on Motion to Appear Pro Hac Vice (2) Docket Text: ORDER granting [122] MOTION for Pro Hac Vice Appearance of Attorney Andrea Brockway. Signed by Judge Mitchell S. Goldberg on 6/14/2022. (nmg) |
| Jun 3, 2022 | 120 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Christopher Hall as co-counsel. Reason for request: No longer with the firm of Saul Ewing Arnstein & Lehr LLP. (Streifthau-Livizos, Michelle) |
| Jun 3, 2022 | 121 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Michelle Streifthau-Livizos on behalf of AbbVie Inc. (Streifthau-Livizos, Michelle) |
| May 26, 2022 | 119 | Letter (1) Docket Text: Letter to The Honorable Mitchell S. Goldberg from Michelle C. Streifthau-Livizos regarding Joint Letter regarding Markman Hearing on July 12, 2022. (Streifthau-Livizos, Michelle) |
| May 20, 2022 | 117 | Claim Construction Reply Brief (22) Docket Text: CLAIM CONSTRUCTION REPLY BRIEF Defendants' Reply Claim Construction Brief filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Wilson, Samantha) |
| May 20, 2022 | 118 | Claim Construction Reply Brief (18) Docket Text: CLAIM CONSTRUCTION REPLY BRIEF filed by AbbVie Inc.. (Taylor, James) |
| May 3, 2022 | 115 | Claim Construction Answering Brief (25) Docket Text: CLAIM CONSTRUCTION ANSWERING BRIEF Defendants' Responsive Claim Construction Brief filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Gaza, Anne) |
| May 3, 2022 | 116 | Main Document (23) Docket Text: CLAIM CONSTRUCTION ANSWERING BRIEF filed by AbbVie Inc.. (Attachments: # (1) Exhibit 6, # (2) Exhibit 7)(Taylor, James) |
| May 3, 2022 | 116 | Exhibit 6 (2) |
| May 3, 2022 | 116 | Exhibit 7 (103) |
| Apr 8, 2022 | 112 | Letter (1) Docket Text: Letter to The Honorable Mitchell S. Goldberg from Eve H. Ormerod, Esq. regarding Defendants' Technology Tutorial DVD. (Ormerod, Eve) |
| Apr 8, 2022 | 113 | Main Document (30) Docket Text: CLAIM CONSTRUCTION OPENING BRIEF (Defendants' Opening Claim Construction Brief) filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit 1 - 6)(Gaza, Anne) |
| Apr 8, 2022 | 113 | Exhibit 1 - 6 (183) |
| Apr 8, 2022 | 114 | Main Document (21) Docket Text: CLAIM CONSTRUCTION OPENING BRIEF filed by AbbVie Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Technology Tutorial, # (7) Cover Letter)(Taylor, James) |
| Apr 8, 2022 | 114 | Exhibit 1 (58) |
| Apr 8, 2022 | 114 | Exhibit 2 (7) |
| Apr 8, 2022 | 114 | Exhibit 3 (28) |
| Apr 8, 2022 | 114 | Exhibit 4 (8) |
| Apr 8, 2022 | 114 | Exhibit 5 (21) |
| Apr 8, 2022 | 114 | Technology Tutorial (23) |
| Apr 8, 2022 | 114 | Cover Letter (1) |
| Mar 31, 2022 | 108 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Amanda Hoffman - filed by AbbVie Inc.. (Attachments: # (1) Certification of Amanda Hoffman)(Davis, Charles) |
| Mar 31, 2022 | 108 | Certification of Amanda Hoffman (1) |
| Mar 31, 2022 | 109 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME substantial completion of document production to April 28, 2022 - filed by AbbVie Inc.. (Morin, Aubrey) |
| Mar 31, 2022 | 110 | Order on Motion to Appear Pro Hac Vice (2) Docket Text: ORDER granting [108] MOTION for Pro Hac Vice Appearance of Attorney Amanda Hoffman. Signed by Judge Mitchell S. Goldberg on 3/31/2022. (nmg) |
| Mar 31, 2022 | 111 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER to extend the Substantial Completion Deadline until April 28, 2022. Signed by Judge Mitchell S. Goldberg on 3/31/2022. (nmg) |
| Mar 21, 2022 | 106 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendants' 1) Objections and Responses to Plaintiffs' Third Set of Interrogatories (Nos. 10-13), and 2) Responses to Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 68-76) filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Ormerod, Eve) |
| Mar 21, 2022 | 107 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc., and Alembic Global Holding SA's Responses and Objections to Plaintiffs' Second Set of Requests for Production of Documents and Things (Nos. 68-76); and 2) Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc., and Alembic Global Holding SA's Responses and Objections to Plaintiffs' Second Set of Interrogatories (Nos. 9-12) filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Wilson, Samantha) |
| Mar 16, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Autumn N. Nero,Brandon M. White,Christopher D. Jones, and Jonathan I Tietz for Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Mar 16, 2022 | 105 | Order on Motion to Appear Pro Hac Vice (2) Docket Text: ORDER granting [104] MOTION for Pro Hac Vice Appearance of Attorney Autumn N. Nero, Brandon M. White, Christopher D. Jones, Jonathan I. Tietz. Signed by Judge Mitchell S. Goldberg on 3/16/2022. (nmg) |
| Mar 15, 2022 | 104 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Autumn N. Nero, Brandon M. White, Christopher D. Jones, Jonathan I. Tietz - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) |
| Mar 9, 2022 | 103 | Main Document (22) Docket Text: CLAIM Construction Chart by AbbVie Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L PART ONE, # (13) Exhibit L PART TWO, # (14) Exhibit M, # (15) Exhibit N)(Taylor, James) |
| Mar 9, 2022 | 103 | Exhibit A (38) |
| Mar 9, 2022 | 103 | Exhibit B (39) |
| Mar 9, 2022 | 103 | Exhibit C (39) |
| Mar 9, 2022 | 103 | Exhibit D (27) |
| Mar 9, 2022 | 103 | Exhibit E (27) |
| Mar 9, 2022 | 103 | Exhibit F (50) |
| Mar 9, 2022 | 103 | Exhibit G (21) |
| Mar 9, 2022 | 103 | Exhibit H (161) |
| Mar 9, 2022 | 103 | Exhibit I (20) |
| Mar 9, 2022 | 103 | Exhibit J (164) |
| Mar 9, 2022 | 103 | Exhibit K (55) |
| Mar 9, 2022 | 103 | Exhibit L PART ONE (95) |
| Mar 9, 2022 | 103 | Exhibit L PART TWO (92) |
| Mar 9, 2022 | 103 | Exhibit M (14) |
| Mar 9, 2022 | 103 | Exhibit N (42) |
| Mar 8, 2022 | 102 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER. Signed by Judge Mitchell S. Goldberg on 3/8/2022. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG(nmg) |
| Mar 7, 2022 | 101 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME to submit a Joint Claim Construction Statement to March 8, 2022 - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) |
| Mar 4, 2022 | 99 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Amended Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by AbbVie Inc..(Morin, Aubrey) |
| Mar 4, 2022 | 100 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME Submission of Joint Claim Construction Statement and other Claim Construction deadlines to 3/7/2022 - filed by AbbVie Inc.. (Morin, Aubrey) |
| Mar 2, 2022 | 97 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME to submit a Joint Claim Construction Statement to March 4, 2022 - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) |
| Mar 2, 2022 | 98 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER to extend time to submit a Joint Claim Construction Statement to March 4, 2022. Signed by Judge Mitchell S. Goldberg on 3/2/2022. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG(nmg) |
| Mar 1, 2022 | 96 | Stipulation and Order (3) Docket Text: STIPULATION AND ORDER to Extend Time. Signed by Judge Mitchell S. Goldberg on 3/1/2022. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG(nmg) |
| Feb 28, 2022 | 95 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME Joint Claim Construction Statement to March 2, 2022 - filed by AbbVie Inc.. (Taylor, James) |
| Feb 21, 2022 | 93 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's third set of interrogatories and third set of requests for production directed to Dr. Reddy's Laboratory filed by AbbVie Inc..(Morin, Aubrey) |
| Feb 21, 2022 | 94 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Second Set of Requests for Production and Second Set of Interrogatories directed to Alembic filed by AbbVie Inc..(Morin, Aubrey) |
| Feb 15, 2022 | 92 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Proposed Terms for Claim Construction and Proposed Claim Constructions filed by AbbVie Inc..(Morin, Aubrey) |
| Feb 14, 2022 | 91 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendants' Preliminary Identification of Claim Terms and Proposed Constructions for U.S. Patent Nos. 9,238,649; 10,993,942; and 11,110,087 filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Ormerod, Eve) |
| Feb 4, 2022 | 89 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Alembic's Initial Invalidity Contentions with Respect to U.S. Patent No. 9,238,649 filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Wilson, Samantha) |
| Feb 4, 2022 | 90 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions for U.S. Patents Nos. 10,993,942, and 11,110,087 filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Ormerod, Eve) |
| Jan 18, 2022 | 88 | Stipulation and Order (3) Docket Text: STIPULATION AND ORDER TO EXTEND TIME (See Order for further details). Signed by Judge Mitchell S. Goldberg on 1/18/2022. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG(myr) |
| Jan 13, 2022 | 87 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME (see stipulation for various deadlines) to Various Dates - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) |
| Dec 6, 2021 | 85 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Infringement Contentions regarding newly asserted patents upon DRL filed by AbbVie Inc..(Morin, Aubrey) |
| Dec 6, 2021 | 86 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Infringement Contentions regarding newly asserted patents upon Alembic filed by AbbVie Inc..(Morin, Aubrey) |
| Nov 30, 2021 | 84 | Answer to Counterclaim (13) Docket Text: ANSWER to [83] Answer to Amended Complaint, Counterclaim of Alembic Defendants by AbbVie Inc., Genentech, Inc..(Taylor, James) |
| Nov 16, 2021 | 82 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [77] Amended Complaint Answer and Separate Defenses of Defendants Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd. to Second Amended Complaint Against DRL for Patent Infringement by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Ormerod, Eve) |
| Nov 16, 2021 | 83 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [76] Amended Complaint , COUNTERCLAIM against AbbVie Inc., Genentech, Inc. by Alembic Pharmaceuticals, Inc., Alembic Global Holding SA, Alembic Pharmaceuticals Ltd..(Gaza, Anne) |
| Nov 8, 2021 | 81 | Scheduling Order (18) Docket Text: AMENDED SCHEDULING ORDER: Fact Discovery completed by 8/26/2022. Opening Expert Reports due by 10/14/2022. Rebuttal Expert Reports due by 12/16/2022. Expert Discovery due by 4/21/2023. Status Report due by 9/2/2022. Claim Construction Opening Brief due by 3/9/2022. Claim Construction Answering Brief due by 4/12/2022. Claim Construction Reply Brief due by 5/3/2022. A Markman Hearing is set for 7/12/2022 at 09:00 AM before Judge Mitchell S. Goldberg. Signed by Judge Mitchell S. Goldberg on 11/8/2021. (nmg) |
| Nov 5, 2021 | 80 | Stipulation (18) Docket Text: Joint STIPULATION Amend Scheduling Order re [79] Stipulation and Order, by AbbVie Inc., Genentech, Inc.. (Taylor, James) |
| Oct 21, 2021 | 78 | Main Document (2) Docket Text: Letter to The Honorable Mitchell S. Goldberg from James D. Taylor, Jr. regarding Stipulation and Proposed Order to Stay Joint Claim Construction Deadline. (Attachments: # (1) Exhibit Stipulation and Proposed Order to Stay Joint Claim Construction Deadline)(Taylor, James) |
| Oct 21, 2021 | 78 | Exhibit Stipulation and Proposed Order to Stay Joint Claim Construction Deadline (3) |
| Oct 21, 2021 | 79 | Stipulation and Order (3) Docket Text: STIPULATION AND ORDER, it is hereby stipulated and agreed, subject to the approval and Order of the Court, that the Parties deadline to exchange the Joint Claim Construction Chart is stayed while the parties meet and confer to propose an amended scheduling order. (See Stipulation and Order for further details)Signed by Judge Mitchell S. Goldberg on 10/21/21. (mal) |
| Oct 19, 2021 | 76 | Main Document (21) Docket Text: Second AMENDED COMPLAINT as to Alembic Defendants against AbbVie Inc., Genentech, Inc.- filed by AbbVie Inc., Genentech, Inc.. (Attachments: # (1) Exhibit Comparison version, # (2) Exhibit A-E)(Taylor, James) |
| Oct 19, 2021 | 76 | Exhibit Comparison version (22) |
| Oct 19, 2021 | 76 | Exhibit A-E (170) |
| Oct 19, 2021 | 77 | Main Document (22) Docket Text: Second AMENDED COMPLAINT as to DRL Defendants against AbbVie Inc., Genentech, Inc.- filed by AbbVie Inc., Genentech, Inc.. (Attachments: # (1) Exhibit Comparison version, # (2) Exhibit A-F)(Taylor, James) |
| Oct 19, 2021 | 77 | Exhibit Comparison version (23) |
| Oct 19, 2021 | 77 | Exhibit A-F (651) |
| Oct 19, 2021 | 76 | Amended Complaint* (1) |
| Oct 19, 2021 | 77 | Amended Complaint* (1) |
| Oct 18, 2021 | 75 | Order (2) Docket Text: ORDER re [74] STIPULATION, Plaintiffs are granted leave to file a second amended complaint against DRL and shall file such second amended complaint within two business days. (See Order for further details) Signed by Judge Mitchell S. Goldberg on 10/18/2021. (smg) |
| Oct 15, 2021 | 72 | Main Document (3) Docket Text: STIPULATION Plaintiffs to file second amended complaint as to Alembic Defendants by AbbVie Inc., Genentech, Inc.. (Attachments: # (1) Exhibit A-Second Amended Complaint, # (2) Exhibit B-Comparison Version)(Taylor, James) |
| Oct 15, 2021 | 72 | Exhibit A-Second Amended Complaint (192) |
| Oct 15, 2021 | 72 | Exhibit B-Comparison Version (23) |
| Oct 15, 2021 | 73 | Stipulation and Order (3) Docket Text: ORDER re [72] STIPULATION, Plaintiffs are granted leave to file their proposed Second Amended Complaint against Alembic and shall file such Second Amended Complaint within two business days of the grant of this stipulated order. Alembic's deadline to move against, answer, or otherwise respond to Plaintiffs' Second Amended Complaint shall be twenty-eight (28) days after the filing and service of the Second Amended Complaint. Signed by Judge Mitchell S. Goldberg on 10/15/2021. (smg) |
| Oct 15, 2021 | 74 | Main Document (2) Docket Text: STIPULATION Plaintiffs to file second amended complaint as to Dr. Reddy Laboratory Defendants by AbbVie Inc., Genentech, Inc.. (Attachments: # (1) Exhibit A-Second Amended Complaint, # (2) Exhibit B-Comparison Version)(Taylor, James) |
| Oct 15, 2021 | 74 | Exhibit A-Second Amended Complaint (674) |
| Oct 15, 2021 | 74 | Exhibit B-Comparison Version (24) |
| Sep 27, 2021 | 70 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Joint Interrogatories (Nos. 1-9) filed by AbbVie Inc., Genentech, Inc..(Taylor, James) |
| Sep 27, 2021 | 71 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Preliminary Identification of Claim Terms and Proposed Constructions filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Wilson, Samantha) |
| Sep 24, 2021 | 68 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Joint Interrogatories (Nos. 1-90) filed by AbbVie Inc., Genentech, Inc..(Taylor, James) |
| Sep 24, 2021 | 69 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Dr. Reddy's First Set of Interrogatories (No. 1) filed by AbbVie Inc., Genentech, Inc..(Taylor, James) |
| Sep 23, 2021 | 66 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME to Exchange a List of Claim Term(s)/Phrase(s) for Construction and Proposed Claim Constructions to September 27, 2021 - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) |
| Sep 23, 2021 | 67 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER TO EXTEND TIME, the deadline for the parties to exchange a list of those claim term(s)/phrase(s) for construction and their proposed claim constructions of such term(s)/phrase(s) shall be extended from September 23, 2021 to September 27, 2021 (See Order for further details). Signed by Judge Mitchell S. Goldberg on 9/23/2021. (mal) |
| Sep 22, 2021 | 65 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER, the deadline for substantial completion of document production shall be extended from October 14, 2021 to November 29, 2021. (See Order for further details). Signed by Judge Mitchell S. Goldberg on 09/22/2021. (smg) |
| Sep 21, 2021 | 64 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME of Substantial Completion of Document Production to November 29, 2021 - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Belgam, Neal) |
| Sep 10, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Amlan Ray for Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Sep 2, 2021 | 63 | Order on Motion to Appear Pro Hac Vice (2) Docket Text: ORDER granting [61] Motion to Appear Pro Hac Vice for Amlan Ray. Signed by Judge Mitchell S. Goldberg on 09/02/2021. (smg) |
| Sep 1, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Grace Tuyiringire for Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Sep 1, 2021 | 62 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Responses and Objections to Plaintiffs AbbVie Inc. and Genentech, Inc.s Second Set of Interrogatories (No. 9), and Responses and Objections to Second Set of Request for the Production of Documents and Things (Nos. 66-67) filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Ormerod, Eve) |
| Aug 31, 2021 | 61 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Amlan Ray - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Attachments: # (1) Certification, # (2) Proposed Order)(Ormerod, Eve) |
| Aug 31, 2021 | 61 | Certification (1) |
| Aug 31, 2021 | 61 | Proposed Order (1) |
| Aug 27, 2021 | 60 | Order on Motion to Appear Pro Hac Vice (2) Docket Text: ORDER, granting D.I.[59] Motion to Appear Pro Hac Vice of Attorney Grace Tuyiringire for Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc., and Alembic Global Holdings SA. Signed by Judge Mitchell S. Goldberg on 8/27/2021. (myr) |
| Aug 25, 2021 | 58 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' First Set of Joint Interrogatories to Plaintiffs (Nos. 1-9) filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Wilson, Samantha) |
| Aug 25, 2021 | 59 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Grace Tuyiringire - filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Wilson, Samantha) |
| Aug 24, 2021 | 56 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of First Set of Interrogatories (No. 1) to Plaintiffs AbbVie Inc and Genentech, Inc. filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Ormerod, Eve) |
| Aug 24, 2021 | 57 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' First Set of Joint Requests for the Production of Documents and Things (Nos. 1-90) filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Wilson, Samantha) |
| Aug 2, 2021 | 55 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' second set of Interrogatories and Requests for Production direced to DRL filed by AbbVie Inc., Genentech, Inc..(Taylor, James) |
| Jul 22, 2021 | 54 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Wilson, Samantha) |
| Jul 21, 2021 | 53 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Initial Invalidity Contentions Relating to U.S. Patent Nos. 8,546,399 and 9,174,982 filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Ormerod, Eve) |
| Jul 16, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Adam C. LaRock for Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., and Alembic Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Jul 15, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re D.I. [52] MOTION for Pro Hac Vice Appearance of Attorney Adam C. LaRock filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. Signed by Judge Mitchell S. Goldberg on 7/15/2021. (myr) |
| Jul 13, 2021 | 52 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Adam C. LaRock - filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Wilson, Samantha) |
| Jul 12, 2021 | 50 | Stipulation and Order (2) Docket Text: STIPULATION TO EXTEND TIME to Serve Defendants' Initial Invalidity Contentions to July 14, 2021 (D.I. [48]) is DENIED as MOOT. Signed by Judge Mitchell S. Goldberg on 7/12/2021. (nmg) Modified on 7/12/2021 (nmg). |
| Jul 12, 2021 | 51 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER to Serve Defendants' Initial Invalidity Contentions to July 21, 2021. Signed by Judge Mitchell S. Goldberg on 7/12/2021. (nmg) |
| Jul 9, 2021 | 49 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Serve Defendants' Initial Invalidity Contentions to July 21, 2021 - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) |
| Jul 6, 2021 | 48 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Serve Defendants' Initial Invalidity Contentions to July 14, 2021 - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) |
| Jun 8, 2021 | 44 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions served upon Alembic Pharmaceuticals. Ltd., Alembic Pharmaceuticals, Inc. and Alembic Global Holdings SA filed by AbbVie Inc., Genentech, Inc..(Taylor, James) |
| Jun 8, 2021 | 45 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions served upon Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. filed by AbbVie Inc., Genentech, Inc..(Taylor, James) |
| Jun 8, 2021 | 46 | Stipulation (13) Docket Text: STIPULATION and Proposed Order Regarding Discovery of Electronically Stored Information by AbbVie Inc., Genentech, Inc. (Taylor, James) |
| Jun 8, 2021 | 47 | Stipulation and Order (13) Docket Text: STIPULATION AND ORDER regarding discovery of electronically stored information and hard copy documents. Signed by Judge Mitchell S. Goldberg on 6/8/2021. (nmg) |
| Jun 2, 2021 | 43 | Order (3) Docket Text: SO ORDERED - re [42] STIPULATION TO EXTEND TIME for Parties to submit ESI Agreement to June 8, 2021. Signed by Judge Mitchell S. Goldberg on 6/2/2021. (amf) |
| Jun 1, 2021 | 42 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME Parties to submit ESI Agreement to June 8, 2021 - filed by AbbVie Inc., Genentech, Inc.. (Taylor, James) |
| May 24, 2021 | 40 | Order (4) Docket Text: Procedure and Order for narrowing the number of asserted claims and prior art references for trial. Signed by Judge Mitchell S. Goldberg on 5/24/2021. (nmg) |
| May 24, 2021 | 41 | Protective Order (21) Docket Text: STIPULATED PROTECTIVE ORDER. Signed by Judge Mitchell S. Goldberg on 5/24/2021. (nmg) |
| May 17, 2021 | 38 | Main Document (1) Docket Text: Letter to The Honorable Mitchell S. Goldberg from James D. Taylor, Jr. regarding Narrowing of Issues. (Attachments: # (1) Text of Proposed Order Proposed Narrowing of Issues)(Taylor, James) |
| May 17, 2021 | 38 | Text of Proposed Order Proposed Narrowing of Issues (4) |
| May 17, 2021 | 39 | Stipulation (21) Docket Text: STIPULATION Proposed Stipulated Protective Order by AbbVie Inc., Genentech, Inc.. (Taylor, James) |
| May 11, 2021 | 37 | SO ORDERED (3) Docket Text: SO ORDERED - re [36] STIPULATION TO EXTEND TIME Parties' Deadline to Submit Case Narrowing Proposal and Extending Plaintiffs' Deadline to Serve Initial Claim Charts to May 17, 2021 for parties case narrowing proposal/two weeks after Court enters a case narrowing order. Signed by Judge Mitchell S. Goldberg on 5/11/2021. (amf) |
| May 10, 2021 | 36 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME Parties' Deadline to Submit Case Narrowing Proposal and Extending Plaintiffs' Deadline to Serve Initial Claim Charts to May 17, 2021 for parties case narrowing proposal/two weeks after Court enters a case narrowing order for Plaintiffs' initial claim charts - filed by AbbVie Inc., Genentech, Inc.. (Taylor, James) |
| May 3, 2021 | 35 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Core Technical Document Production and Related Disclosures, Pursuant to Paragraph 8(c) of the Scheduling Order filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Ormerod, Eve) |
| Apr 30, 2021 | 34 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alembic's core technical document production and related disclosures, pursuant to Paragraph 8(c) of the Scheduling Order filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Wilson, Samantha) |
| Apr 21, 2021 | 32 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-65) and 2) Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-8) filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Ormerod, Eve) |
| Apr 21, 2021 | 33 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc., and Alembic Global Holding SA's Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-8) and 2) Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc., and Alembic Global Holding SA's Responses and Objections to Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-67) filed by Alembic Global Holding SA, Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc..(Wilson, Samantha) |
| Apr 15, 2021 | 31 | Scheduling Order (14) Docket Text: ORDER, C.A. No. 20-1009-MSG shall be consolidated with C.A. No. 20-00968-MSG (the Consolidated Action) for all purposes, and all papers shall be filed in the Consolidated Action. SCHEDULING ORDER: Joinder of Parties due by 10/15/2021. Amended Pleadings due by 10/15/2021. Fact Discovery completed by 5/5/2022. Opening Expert Reports due by 7/22/2022. Rebuttal Expert Reports due by 9/23/2022. Status Report due by 5/12/2022. Claim Construction Opening Brief due by 11/10/2021. Claim Construction Answering Brief due by 12/9/2021. Claim Construction Reply Brief due by 1/11/2022. A Markman Hearing is set for 2/24/2022 at 09:00 AM before Judge Mitchell S. Goldberg. **(See Order for further details.) Signed by Judge Mitchell S. Goldberg on 4/15/2021. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG(nmg) |
| Mar 19, 2021 | 30 | Transcript (18) Docket Text: Official Transcript of Rule 16 Teleconference held on 3/11/2021 before Judge Judge Mitchell S. Goldberg. Court Transcriber Neal R. Gross, (202) 234-4433. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 4/9/2021. Redacted Transcript Deadline set for 4/19/2021. Release of Transcript Restriction set for 6/17/2021. (nmg) |
| Mar 16, 2021 | 27 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Rule 26(a) Initial Disclosures and 2) Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Ormerod, Eve) |
| Mar 16, 2021 | 28 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures, Paragraph 3 Disclosures and Identification of Asserted Patents filed by AbbVie Inc., Genentech, Inc..(Taylor, James) |
| Mar 16, 2021 | 29 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories and First Set of Requests for Production to Defendant filed by AbbVie Inc., Genentech, Inc..(Taylor, James) |
| Mar 12, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christopher R. Hall for AbbVie Inc., for Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Mar 11, 2021 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Telephone Conference held on 3/11/2021 (25 minutes). (myr) |
| Mar 11, 2021 | 25 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher R. Hall - filed by AbbVie Inc., Genentech, Inc.. (Attachments: # (1) Certification of Counsel)(Taylor, James) |
| Mar 11, 2021 | 25 | Certification of Counsel (1) |
| Mar 11, 2021 | 26 | Order on Motion to Appear Pro Hac Vice (2) Docket Text: ORDER granting [25] Motion to Appear Pro Hac Vice of Attorney Christopher R. Hall in cases 1:20-cv-00968-MSG, 1:20-cv-01009-MSG. Signed by Judge Mitchell S. Goldberg on 3/11/2021. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG. (kmd) |
| Mar 9, 2021 | 24 | Proposed Order (16) Docket Text: PROPOSED ORDER Joint Proposed Scheduling Order by AbbVie Inc., Genentech, Inc.. (Taylor, James) |
| Mar 8, 2021 | 23 | Stipulation and Order (2) Docket Text: JOINT STIPULATION AND ORDER Extending Date for Filing Joint Report of the Rule 26(f) Meeting. Signed by Judge Mitchell S. Goldberg on 3/8/2021. (kmd) |
| Mar 5, 2021 | 22 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME filing of joint discovery plan to March 9, 2021 - filed by AbbVie Inc., Genentech, Inc.. (Taylor, James) |
| Feb 16, 2021 | 20 | Stipulation and Order (2) Docket Text: Joint STIPULATION AND ORDER. Signed by Judge Mitchell S. Goldberg on 2/16/2021. (nmg) |
| Feb 16, 2021 | 21 | Order (1) Docket Text: ORDER, the Initial Pretrial Conference is RESCHEDULED for Thursday, March 11, 2021 at 10:00 AM before Judge Mitchell S. Goldberg. The conference will be conducted via telephone and held on the record. Counsel are directed to dial in to 571-353-2300, passcode 427102124#. Signed by Judge Mitchell S. Goldberg on 2/16/2021. (nmg) |
| Feb 11, 2021 | 19 | Main Document (2) Docket Text: Letter to Judge Mitchell S. Goldberg from James D. Taylor, Jr. regarding Scheduling Conference and Deadlines for Initial Disclosures. (Attachments: # (1) Stipulation)(Taylor, James) |
| Feb 11, 2021 | 19 | Stipulation (2) |
| Jan 28, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Anandita Vyakarnam for Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Jan 28, 2021 | 18 | Order Setting Teleconference (1) Docket Text: ORDER - An Initial Pretrial Conference in the above-captioned matter will be held on Wednesday, March 10, 2021 at 10:00 a.m. The conference will be conducted via telephone and held on the record. Counsel are directed to dial in to 571-353-2300, passcode 427102124#. Counsel shall consult Judge Goldberg's Policies and Procedures (available at http://www.paed.uscourts.gov) prior to the conference. Signed by Judge Mitchell S. Goldberg on 1/28/2021. (amf) |
| Jan 22, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Mitchell S. Goldberg of the United States District Court for the Eastern District of Pennsylvania. Please include the initials of the Judge (MSG) after the case number on all documents filed. Associated Cases: 1:20-cv-00968-MSG, 1:20-cv-01009-MSG (rjb) |
| Jan 22, 2021 | 16 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Anandita Vyakarnam - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Belgam, Neal) |
| Jan 22, 2021 | 17 | SO ORDERED (2) Docket Text: SO ORDERED, re D.I. [16] MOTION for Pro Hac Vice Appearance of Attorney Anandita Vyakarnam filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. Signed by Judge Mitchell S. Goldberg on 1/22/2021. (myr) |
| Dec 3, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Scott F. Peachman for AbbVie Inc. and Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00968-LPS, 1:20-cv-01009-LPS(mal) |
| Nov 12, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] MOTION for Pro Hac Vice Appearance of Attorney Scott F. Peachman filed by Genentech, Inc., AbbVie Inc. Signed by Judge Leonard P. Stark on 11/12/20. (ntl) |
| Nov 12, 2020 | 15 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Scott F. Peachman - filed by AbbVie Inc., Genentech, Inc.. (Attachments: # (1) Certification of Counsel)(Taylor, James) |
| Nov 12, 2020 | 15 | Certification of Counsel (1) |
| Oct 19, 2020 | 14 | Answer to Amended Complaint (29) Docket Text: ANSWER to Amended Complaint, re: [13] Amended Complaint, and Separate Defenses by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Ormerod, Eve) |
| Sep 28, 2020 | 13 | Main Document (19) Docket Text: AMENDED COMPLAINT against Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.- filed by AbbVie Inc., Genentech, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Patent/Trademark Report, # (6) ANDA Form)(Taylor, James) |
| Sep 28, 2020 | 13 | Exhibit A (266) |
| Sep 28, 2020 | 13 | Exhibit B (254) |
| Sep 28, 2020 | 13 | Exhibit C (38) |
| Sep 28, 2020 | 13 | Exhibit D (39) |
| Sep 28, 2020 | 13 | Patent/Trademark Report (1) |
| Sep 28, 2020 | 13 | ANDA Form (2) |
| Sep 28, 2020 | 13 | Amended Complaint* (1) |
| Sep 25, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] Stipulation and Order Regarding First Amended Complaint filed by Genentech, Inc., AbbVie Inc. Signed by Judge Leonard P. Stark on 9/22/20. (ntl) |
| Sep 21, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Constance S. Huttner and Beth C. Finkelstein for Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Sep 18, 2020 | 12 | Main Document (2) Docket Text: STIPULATION Plaintiffs to file First Amended Complaint by AbbVie Inc., Genentech, Inc.. (Attachments: # (1) First Amended Complaint, # (2) Red Line Comparison, # (3) Exhibit A, # (4) Exhibit B, # (5) Exhibit C, # (6) Exhibit D)(Taylor, James) |
| Sep 18, 2020 | 12 | First Amended Complaint (19) |
| Sep 18, 2020 | 12 | Red Line Comparison (19) |
| Sep 18, 2020 | 12 | Exhibit A (266) |
| Sep 18, 2020 | 12 | Exhibit B (254) |
| Sep 18, 2020 | 12 | Exhibit C (38) |
| Sep 18, 2020 | 12 | Exhibit D (39) |
| Sep 10, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney Constance S. Huttner and Beth Finkelstein filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. Signed by Judge Leonard P. Stark on 9/10/20. (ntl) |
| Sep 8, 2020 | 11 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Constance S. Huttner and Beth Finkelstein - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) |
| Aug 28, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Ashley N. Mays-Williams for AbbVie Inc. and Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01009-LPS, 1:20-cv-00968-LPS(kmd) |
| Aug 14, 2020 | 9 | Answer to Complaint (25) Docket Text: ANSWER to [1] Complaint, and Separate Defenses by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Ormerod, Eve) |
| Aug 14, 2020 | 10 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Dr. Reddy's Laboratories, Ltd. for Dr. Reddys Laboratories, Inc. filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) |
| Aug 4, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Chad J. Peterman, Eric W. Dittmann, Bruce M. Wexler for AbbVie Inc. and Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Aug 4, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Eric W. Dittmann for AbbVie Inc. and Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Aug 4, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Katherine A. Daniel and Krystina Ho for AbbVie Inc. and Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Aug 4, 2020 | 8 | Main Document (2) Docket Text: AFFIDAVIT of Service for Complaint served on Andrew J. Miller, Esq. on July 24, 2020, filed by AbbVie Inc., Genentech, Inc.. (Attachments: # (1) Exhibit A & B)(Taylor, James) |
| Aug 4, 2020 | 8 | Exhibit A & B (8) |
| Jul 30, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [7] MOTION for Pro Hac Vice Appearance of Attorney Chad Peterman, Eric Dittmann, Bruce Wexler, Ashley Mays-Williams, Katherine Daniel and Krystina Ho filed by Genentech, Inc., AbbVie Inc. Signed by Judge Leonard P. Stark on 7/30/20. (ntl) |
| Jul 29, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Jul 29, 2020 | 7 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Chad Peterman, Eric Dittmann, Bruce Wexler, Ashley Mays-Williams, Katherine Daniel and Krystina Ho - filed by AbbVie Inc., Genentech, Inc.. (Taylor, James) |
| Jul 28, 2020 | N/A | Remark (0) Docket Text: Remark: Civil Cover Sheet updated per counsel's request. (kmd) |
| Jul 28, 2020 | 6 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 8, 2020. Date of Expiration of Patent: 06/27/2031; 01/29/2032; 05/26/2030.Thirty Month Stay Deadline: 10/11/2023. (Taylor, James) |
| Jul 22, 2020 | 4 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc.. (Taylor, James) |
| Jul 22, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holdings, Inc. for Genentech, Inc. filed by Genentech, Inc.. (Taylor, James) |
| Jul 21, 2020 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (mal) |
| Jul 21, 2020 | 1 | Main Document (17) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3076240.) - filed by AbbVie Inc., Genentech, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Civil Cover Sheet)(mal) (Attachment 4 replaced on 7/28/2020) (kmd). |
| Jul 21, 2020 | 1 | Exhibit A (266) |
| Jul 21, 2020 | 1 | Exhibit B (254) |
| Jul 21, 2020 | 1 | Exhibit C (38) |
| Jul 21, 2020 | 1 | Civil Cover Sheet (2) |
| Jul 21, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Jul 21, 2020 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,546,399 ;9,174,982 ;8,722,657. (mal) |
| Jul 21, 2020 | 1 | Complaint* (1) |
